Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection Journal Article


Authors: Zelenetz, A. D.; Chen, T. T.; Levy, R.
Article Title: Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection
Abstract: The genesis of human follicular lymphoma (FL) is a multistep process. The initial event is thought to be the chromosomal translocation t(14;18)(q32;q21)juxtaposing the bcl-2 proto-oncogene with the immunoglobulin (Ig) H chain locus joining segment (JH) as an error of D-J or V-D joining in the pre-B cell. However, FL is recognized clinically as a tumor of surface Ig (slg)-positive B cells with morphologic and phenotypic similarities to the centrocyte of the secondary immune response. Thus, additional steps must be involved in the clonal expansion of the FL tumor cell beyond the activation of bcl-2 as a consequence of the t(14;18) translocation. Like the normal centrocyte, somatic mutations accumulate in the variable (V) genes of FL tumor B cells. To determine if clonal expansion of FL occurs before or after the development of the malignant follicle, we sought to examine the evolution of the FL V gene from its unmutated germline (GL) counterpart. To obtain the GL gene we first cloned the productively rearranged V gene of patient MT FL and obtained the clone rMTF. A hybridization probe derived from the 2.1-kb region upstream of the V gene in clone rMTF identified a single band in Southern blot hybridization of GL DNA. This probe was used to screen a size-selected library, and candidate GL V genes were isolated. Two identical clones, MTGL1 and 2, proved to have upstream regions (USRs) that were colinear with the USR of the rMTF. Thus, the MTGL clones represent the unmutated GL V genes, which were productively rearranged in the MT FL. Comparison of the GL V gene sequence to a consensus of MT FL V gene sequences revealed 42 mutations, demonstrating that malignant clonal expansion occurred subsequent to the activation of somatic mutation, presumably in the malignant follicle. Furthermore, the individual FL V gene sequences segregated into two distinct patterns of mutation. The major population represented 71% of the clones, and the minor population 29%. To investigate possible mechanisms for the parallel selection of distinct tumor cell populations, we analyzed the pattern of silent and replacement mutations within the V gene sequences. We found that in the framework regions (FRs) of both populations there were significantly fewer replacement changes than expected, suggesting that negative selective pressure was maintaining the structural integrity of the slg. In contrast, the complementarity determining regions (CDRs), which make up the antigen binding domain of Ig, had an excess of replacement changes, suggesting positive selection for altered ligand binding. The findings of positive selection of CDRs and of negative selection of FRs support the hypothesis that the slg was under selective pressure, presumably by antigen in both subpopulations of this tumor. Thus, we propose a model of stepwise development of FL beginning with the t(14;18) translocation followed by antigen-driven clonal expansion. © 1992, Rockefeller University Press., All rights reserved.
Keywords: gene mutation; gene sequence; gene translocation; human cell; mutation; proto-oncogene proteins; polymerase chain reaction; proto oncogene; tumor cells, cultured; rna; molecular cloning; cloning, molecular; gene mapping; dna; immunoglobulin heavy chain; gene rearrangement; immunoglobulin variable region; molecular sequence data; antigen; dna, neoplasm; tumor cell; plasmid; base sequence; tumor growth; sequence homology; oligonucleotide; follicular lymphoma; proto-oncogene proteins c-bcl-2; lymphoma, follicular; multigene family; genetic complementation; oligodeoxyribonucleotides; southern blotting; restriction mapping; chromosomes, human, pair 14; chromosomes, human, pair 18; blotting, southern; genomic library; human; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; translocation (genetics); immunoglobulins, heavy-chain
Journal Title: Journal of Experimental Medicine
Volume: 176
Issue: 4
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 1992-10-01
Start Page: 1137
End Page: 1148
Language: English
DOI: 10.1084/jem.176.4.1137
PUBMED: 1402658
PROVIDER: scopus
PMCID: PMC2119381
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    768 Zelenetz